What Kreg Therapeutics does

Kreg Therapeutics, LLC is a private US medical device company founded in 1996 and headquartered in Melrose Park, Illinois, that designs, assembles, and rents specialty hospital beds and therapeutic support surfaces targeting complex ICU, bariatric, and trauma patients. The flagship product is the Catalyst® critical recovery bed, which features the company's proprietary In-Bed Verticalization™ therapy platform, gradually tilting patients from supine to a head-up, foot-down standing position without hip flexion, enabling early mobilization of patients—including bariatric patients up to 750 lbs—who cannot be safely transferred out of bed. Supporting technologies include the X-Hale Chair™ with Lumbar Boost™, Continuous Lateral Rotation Therapy (CLRT), Accelerated Offloading surface pressure management, and Direct Surface Airflow microclimate control. The E-Z Wider® bariatric bed (1,000 lb capacity) with Close Care™ expandable width technology and the Composure® mattress line round out the product portfolio.

Kreg operates a hybrid revenue model combining full-service rental with direct hardware sales, supported by a nationwide network of regional Service Centers positioned within three hours of customers for rapid delivery and 24/7 service response. Customers are primarily US acute-care hospitals and health systems, with the company stating its beds are trusted by 50% of top US trauma centers. Pricing is structured through a multi-year Premier GPO contract (BT-NS-023) that took effect February 1, 2026 under Premier's Breakthrough Technology Designation, granting Premier member hospitals pre-negotiated access and effectively institutionalizing the product in the US value-analysis process.

The company is owned by middle-market private equity firm Milton Street Capital. The leadership team was substantially rebuilt between 2022 and 2024 from Hillrom and Baxter alumni, including CEO Christian Jorgensen (joined September 2022), with founder Craig Poulos continuing as lead inventor and board member. Kreg has assembled an extensive patent estate covering electromechanical medical devices for specialty beds and mattresses (over 20 US and international patents with six pending), and in April 2026 filed a patent infringement and false advertising suit against competitor VitalGo.

Name

Kreg Therapeutics

Legal name

Kreg Therapeutics, LLC

Website

https://kreg.us

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

Kreg Therapeutics designs, assembles, and rents specialty hospital beds—including its flagship Catalyst® In-Bed Verticalization™ platform—targeting complex ICU, trauma, and bariatric patients (up to 750 lbs) at US acute-care hospitals and health systems.

Ownership category

akta.pro rank

Product category

Specialty Hospital Beds

NAICS

Home Health Equipment Rental (532283)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Hospital Bed, Lift & Transfer Equipment (Beds, Hoyer Lifts, Slings) (HSABAKAF)

Keywords

• Specialty hospital beds
• ICU early mobility
• Bariatric patient care
• Critical care equipment
• Medical device rentals

Headquarters

HQ city

Melrose Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Bed Rental: Kreg Therapeutics operates a full-service rental model for its specialty beds. The rental includes on-site orientation and hands-on training for all shifts, customized verticalization protocols and order guides, therapy logs, quick reference guides, full training video library, and a dedicated Kreg Clinical Specialist throughout the rental period. Service on all rental units is fully covered with repair or replacement provided at no additional charge. Volume pricing is available for facilities renting multiple Catalyst units.
2. Specialty Bed Sales: Kreg designs and assembles its beds in the USA and sells them directly to healthcare facilities. The company also sells replacement parts for its beds.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Kreg Therapeutics designs, assembles in the USA, and rents or sells specialty hospital beds (The Catalyst® critical recovery bed and the E-Z Wider® bariatric chair-bed) that enable In-Bed Verticalization™ therapy for complex ICU patients, including bariatric patients up to 750 lbs. The full-service rental model bundles the bed with on-site training for all shifts, customized verticalization protocols, a dedicated Kreg Clinical Specialist, and 24/7 service coverage through a nationwide network of regional Service Centers. Direct sales of beds and replacement parts supplement the rental business, with distribution supported by Premier's GPO contract BT-NS-023.

Product overview

Kreg Therapeutics offers a portfolio of specialty hospital beds and therapeutic technologies for complex ICU patients. The core products are The Catalyst® (a critical recovery bed enabling In-Bed Verticalization™ for patients up to 750 lbs) and the E-Z Wider® (a bariatric bed with 1,000 lb capacity offering full chair egress). These are supported by proprietary technologies including X-Hale Chair™ for improved sitting posture, Continuous Lateral Rotation Therapy (CLRT) for pulmonary support, Accelerated Offloading Technology for pressure injury prevention, and Direct Surface Airflow for microclimate management. The company operates a full-service rental model with 24/7 support, clinical training, and nationwide service centers.

Differentiator

Problem solved

Functional benefit

Brands

• Catalyst®: Critical recovery bed enabling In-Bed Verticalization™ for complex ICU patients up to 750 lbs
• E-Z Wider®
• Composure®
• AP Max®
• X-Hale Chair™
• Close Care™
• Lumbar Boost™
• Verticalization Therapy®
• In-Bed Verticalization™

Products and services

• The Catalyst®

Quantifiable outcome

• 83% ECMO survival rate vs. 53% ELSO registry average with zero posterior HAPIs
• +6 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Premier, Inc.coreChannel Partner/ Reseller/ Distributor · 1 February 2026Premier awarded the Catalyst bed a Breakthrough Technology Designation, recognizing it as a clinically differentiated solution supporting operational and financial sustainability. A national group purchasing agreement (BT-NS-023) was established effective February 1, 2026, granting Premier's member hospitals and health systems access to pre-negotiated pricing for the Catalyst bed. Kreg's CEO Christian Jorgensen noted the designation recognizes the bed's ability to reduce length of stay, pressure injuries, and improve caregiver safety in complex ICU settings.
• ArentFox Schiff LLPminorOthersKreg Therapeutics filed a patent infringement and false advertising lawsuit against VitalGo on April 10, 2026 in the U.S. District Court for the Western District of Texas. Kreg is represented in this matter by ArentFox Schiff LLP.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/kregtherapeutics
• Xx.com/kregjobs

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kreg Therapeutics